Oestrogen concentrations in plasma, endometrium, myometrium and vagina of postmenopausal women, and effects of vaginal oestriol (E3) and oestradiol (E2) applications
- 31 October 1989
- journal article
- clinical trial
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 33 (4) , 647-653
- https://doi.org/10.1016/0022-4731(89)90055-1
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Benefits and risks of different hormonal replacement therapies in post-menopausal womenMaturitas, 1986
- THE RISK OF ENDOMETRIAL AND BREAST CANCER AFTER ESTROGEN TREATMENTActa Obstetricia et Gynecologica Scandinavica, 1985
- The endogenous concentration of estradiol and estrone in normal human postmenopausal endometriumThe Journal of Steroid Biochemistry and Molecular Biology, 1984
- A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1983
- A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal womenActa Obstetricia et Gynecologica Scandinavica, 1983
- Plasma concentration gradient of steroid hormones across human mammary tumours in vivoJournal of Steroid Biochemistry, 1981
- Comparison of plasma and myometrial tissue concentrations of estradiol-17β and progesterone in nonpregnant womenContraception, 1981
- A PROSPECTIVE, CONTROLLED TRIAL OF SIX FORMS OF HORMONE REPLACEMENT THERAPY GIVEN TO POSTMENOPAUSAL WOMENBJOG: An International Journal of Obstetrics and Gynaecology, 1979
- THE UPTAKE OF [6,7-3H]OESTRADIOL BY THE NORMAL HUMAN FEMALE REPRODUCTIVE TRACTJournal of Endocrinology, 1967
- Die Wirkung des Oestriol auf Corpus uteri, Cervix uteri und Vagina der FrauDeutsche Medizinische Wochenschrift (1946), 1957